A Form 4 filed with the SEC on August 17, 2026, disclosed that Thomas A. Surran, President and CEO of Resideo Technologies, Inc. (NYSE:REZI), purchased 15,000 shares of common stock on August 14, 2026.

Key Highlights

  • Reporting person: Thomas A. Surran, President and CEO, also listed as a Director of Resideo Technologies, Inc.
  • Transaction: 15,000 shares of common stock acquired (transaction code P) on August 14, 2026.
  • Weighted average price: $20.46 per share, with individual transactions ranging from $20.41 to $20.47, inclusive.
  • Beneficial ownership after transaction: 338,573 shares held directly following the reported purchase.
  • Filing signed: Joshua Foster, as attorney-in-fact, on August 17, 2026.

Resideo Technologies CEO Reports Open-Market Share Purchase

According to the Form 4 filing, Thomas A. Surran, who serves as both a Director and President and CEO of Resideo Technologies, Inc., acquired 15,000 shares of the company's common stock on August 14, 2026. The shares were purchased directly, and the filing lists transaction code "P," indicating an open-market purchase. The filing does not indicate the transaction was made pursuant to a Rule 10b5-1 plan.

The price reported in the filing is a weighted average of $20.46 per share. As noted in the filing's footnote, "The shares were purchased in multiple transactions at prices ranging from $20.41 to $20.47, inclusive." The filing further states that Surran "undertakes to provide to Resideo Technologies, Inc., any securityholder thereof or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."

Following the reported transaction, Surran's direct beneficial ownership of Resideo Technologies common stock stands at 338,573 shares, according to the filing. No derivative securities transactions were reported in Table II of the form.

What Was Disclosed

The filing reports a purchase of 15,000 shares of Resideo Technologies common stock by President and CEO Thomas A. Surran on August 14, 2026, at a weighted average price of $20.46, bringing his direct beneficial ownership to 338,573 shares.